James Investment Research Inc United Therapeutics Corp Transaction History

James Investment Research Inc

$819 Million
Q4 2024

A detailed history of James Investment Research Inc transactions in United Therapeutics Corp stock. As of the latest transaction made, James Investment Research Inc holds 2,665 shares of UTHR stock, worth $837,129. This represents 0.11% of its overall portfolio holdings.

Number of Shares

2,665

Previous 2,809 5.13%

Holding current value

$837,129

Previous $1.01 Million 6.56%

% of portfolio

0.11%

Previous 0.12%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 30, 2025	SELL	$348.66 - $410.0 $50,207 - $59,040	-144 Reduced 5.13%	2,665 $940,000
Q3 2024 Oct 29, 2024	BUY	$311.04 - $363.55 $1,555 - $1,817	5 Added 0.18%	2,809 $1.01 Million
Q2 2024 Jul 30, 2024	SELL	$228.26 - $319.04 $4,336 - $6,061	-19 Reduced 0.67%	2,804 $893,000
Q1 2024 May 01, 2024	SELL	$210.76 - $249.51 $10,327 - $12,225	-49 Reduced 1.71%	2,823 $648,000
Q4 2023 Feb 06, 2024	SELL	$214.88 - $256.94 $2,363 - $2,826	-11 Reduced 0.38%	2,872 $631,000
Q3 2023 Oct 31, 2023	BUY	$211.82 - $248.24 $610,677 - $715,675	2,883 New	2,883 $651,000
Q1 2023 Apr 25, 2023	BUY	$212.99 - $276.17 $53,247 - $69,042	250 Added 114.68%	468 $105,000
Q4 2022 Jan 30, 2023	SELL	$205.95 - $280.43 $10,503 - $14,301	-51 Reduced 18.96%	218 $61,000
Q3 2022 Oct 31, 2022	BUY	$203.3 - $244.17 $36,594 - $43,950	180 Added 202.25%	269 $56,000
Q2 2022 Aug 01, 2022	BUY	$174.81 - $241.14 $15,558 - $21,461	89 New	89 $21,000
Q1 2022 Apr 22, 2022	SELL	$166.16 - $213.96 $31,238 - $40,224	-188 Closed	0 $0
Q4 2021 Jan 28, 2022	BUY	$184.32 - $216.08 $34,652 - $40,623	188 New	188 $41,000
Q2 2019 Jul 24, 2019	SELL	$76.06 - $120.81 $151,283 - $240,291	-1,989 Closed	0 $0
Q1 2019 Apr 26, 2019	SELL	$107.15 - $126.84 $3,214 - $3,805	-30 Reduced 1.49%	1,989 $233,000
Q4 2018 Jan 22, 2019	SELL	$101.4 - $128.73 $1.68 Million - $2.14 Million	-16,611 Reduced 89.16%	2,019 $220,000
Q3 2018 Oct 26, 2018	SELL	$113.81 - $129.46 $318,326 - $362,099	-2,797 Reduced 13.05%	18,630 $2.38 Million
Q2 2018 Jul 19, 2018	BUY	$101.14 - $118.31 $2.17 Million - $2.54 Million	21,427 New	21,427 $2.43 Million

Others Institutions Holding UTHR

# of Institutions

725

Shares Held

61M

Call Options Held

123K

Put Options Held

104K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $14.3B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.

Account

James Investment Research Inc United Therapeutics Corp Transaction History